Stoke Therapeutics
STOK
STOK
70 hedge funds and large institutions have $825M invested in Stoke Therapeutics in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.45% more ownership
Funds ownership: 105.54% → 105.99% (+0.45%)
29% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 24
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
70
Holding in Top 10
1
Calls
$608K
Puts
$5K
Top Buyers
| 1 | +$11.5M | |
| 2 | +$8.02M | |
| 3 | +$7.28M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$3.43M |
| 5 |
Millennium Management
New York
|
+$3.35M |
Top Sellers
| 1 | -$12.2M | |
| 2 | -$7.81M | |
| 3 | -$3.73M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$2.79M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.76M |